The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival

BACKGROUND AND AIM: Primary sclerosing cholangitis (PSC), with or without inflammatory bowel disease (IBD), confers the risk of cholangiocarcinoma. Isolated IBD may be an independent risk factor for cholangiocarcinoma. We sought to compare cholangiocarcinoma phenotype and outcomes between patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahal, Daljeet, Shamatutu, Chris, Salh, Bill, Davies, Janine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731823/
https://www.ncbi.nlm.nih.gov/pubmed/33319047
http://dx.doi.org/10.1002/jgh3.12405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731823/
https://www.ncbi.nlm.nih.gov/pubmed/33319047
http://dx.doi.org/10.1002/jgh3.12405

Ejemplares similares